Cefiderocol for Treatment of Complicated Urinary Tract Infections
Overview
Affiliations
Clinical Distribution and Drug Resistance of in Guangzhou, China from 2017 to 2021.
Lyu J, Chen H, Bao J, Liu S, Chen Y, Cui X J Clin Med. 2023; 12(3).
PMID: 36769837 PMC: 9917919. DOI: 10.3390/jcm12031189.
Clinical experience of cefiderocol.
Farinas M Rev Esp Quimioter. 2022; 35 Suppl 2:35-38.
PMID: 36193983 PMC: 9632058. DOI: 10.37201/req/s02.05.2022.
Acinetobacter baumannii response to cefiderocol challenge in human urine.
Nishimura B, Escalante J, Tuttobene M, Subils T, Mezcord V, Pimentel C Sci Rep. 2022; 12(1):8763.
PMID: 35610334 PMC: 9128776. DOI: 10.1038/s41598-022-12829-7.
Compassionate use of cefiderocol for carbapenem-resistant prosthetic joint infection.
Mabayoje D, NicFhogartaigh C, Cherian B, Tan M, Wareham D JAC Antimicrob Resist. 2021; 3(Suppl 1):i21-i24.
PMID: 34223152 PMC: 8251250. DOI: 10.1093/jacamr/dlab055.
Mushtaq S, Sadouki Z, Vickers A, Livermore D, Woodford N Antimicrob Agents Chemother. 2020; 64(12).
PMID: 32958717 PMC: 7674041. DOI: 10.1128/AAC.01582-20.